Riskpilot← Back to searchSign inGet full accessKarlaplanstandläkarna AB
ABActiveOrg 5567886378Lützengatan 1Dental practice care activities · NACE 8623Est. 20097 employees
Revenue 2025
SEK 12,1M
-3% vs 2024
EBITDA margin
25.3%
+33% vs 2024
Equity ratio
72.8%
Financial strength
Net profit 2025
SEK 2,1M
+33% vs 2024
| Revenue | SEK 12,1M | -3% |
| EBITDA | SEK 3,1M | +33% |
| Net profit | SEK 2,1M | +33% |
| Total assets | SEK 3,6M | +6% |
| Equity | SEK 2,7M | +30% |
| Employees | 7 | — |
Legal name
Karlaplanstandläkarna AB
Org number
5567886378
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
7 september 2009
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandvård, äga och förvalta fast och lös egendom och värdepapper samt bedriva därmed förenlig verksamhet.
Address
Lützengatan 1
Email
info@karlaplanstandlakarna.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 027 | 7 201 | 9 596 | 12 459 | 12 097 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 094 | 2 158 | 2 869 | 2 301 | 3 058 |
| Depreciation & amort. | −50 | −0 | −7 | −254 | −378 |
| EBIT | 2 044 | 2 158 | 2 862 | 2 047 | 2 680 |
| Net financials | −1 | — | −3 | −30 | −7 |
| Profit before tax | 2 043 | 2 157 | 2 859 | 2 017 | 2 672 |
| Tax | −442 | −448 | −609 | −433 | −563 |
| Net profit | 1 601 | 1 709 | 2 250 | 1 584 | 2 109 |
| Item | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 691 | 2 872 | 3 487 | 3 446 | 3 644 |
| Equity | 2 120 | 1 810 | 2 459 | 2 044 | 2 653 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 571 | 1 063 | 1 028 | 1 402 | 991 |
| Total debt | 571 | 1 063 | 1 028 | 1 402 | 991 |
EBITDA margin
25.3%
This company
15.8%
Market median
+60% vs market
20202025
Equity ratio
72.8%
This company
38.2%
Market median
+91% vs market
20202025
Return on equity
79.5%
This company
18.4%
Market median
+332% vs market
20202025
Net profit margin
17.4%
This company
8.1%
Market median
+115% vs market
20202025
Asset turnover
3.32×
This company
1.12×
Market median
+196% vs market
20202025
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20202025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-01-01 – 2024-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Former (1) | ||
CA Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gladent AB
Karlaplanstandläkarna AB Board members of Karlaplanstandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Jörgen Rickard Sivertsson | Audit | 0 companies |
| Christina Agnes Maria Sääf Tranarp | Chief Executive Officer | 0 companies |
| Anna Eva Maria Ermenc | Deputy Board Member | 0 companies |
| Sara Elisabeth Tranarp | Deputy Board Member | 0 companies |
| Mihael Damjan Ermenc | Board of Directors | 0 companies |